You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Perrigo Company announces quarterly dividend
3 August 2023 -

Perrigo Company plc (NYSE: PRGO), an American-Irish provider of Consumer Self Care Products and over-the-counter (OTC) health and wellness solutions, announced its quarterly dividend on Wednesday.

The company has declared quarterly dividend of USD0.273 per share.

The dividend will be paid to shareholders of record at 1 September 2023 on 19 September 2023.

Login
Username:

Password:


Related Headlines

Organon posts Q2 2023 results

Roquefort Therapeutics advances novel siRNA therapeutics

Perrigo Company announces quarterly dividend

Amgen announces Q3 2023 dividend

McKesson Corporation boosts quarterly dividend by 15% to USD0.62 per share

EarliTec Diagnostics Receives FDA 510(k) Authorization for EarliPoint Evaluation for Autism Spectrum Disorder

LimmaTech granted licence by GSK to develop Shigella vaccine

Gilead Partners with CHAI and Penta to Improve Treatment and Adherence Rates Among Children with HIV in Low and Middle Income Countries

Labcorp announces cash dividend

Hansa Biopharma declares recognition of SEK1.430bn write-up for Idefirix in parent company's financial statements

Eli Lilly announces Q3 2023 dividend

AbbVie announces quarterly cash dividend

Abbott announces quarterly common dividend

Genomma Lab Internacional announces cash dividend

GSK Launches COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2023